- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · May 6, 2024 | 63.63M sh |
| Cash And Equivalents | Q3 2024 · Mar 31, 2024 | $7.01M |
| Cash And Equivalents | Q3 2024 · Jun 30, 2023 | $824.92K |
| Current Liabilities | Q3 2024 · Mar 31, 2024 | $3.54M |
| Current Liabilities | Q3 2024 · Jun 30, 2023 | $9.35M |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $20.35M |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $11.47M |
| Current Assets | Q3 2024 · Mar 31, 2024 | $7.79M |
| Current Assets | Q3 2024 · Jun 30, 2023 | $2.3M |
| Total Assets | Q3 2024 · Mar 31, 2024 | $59.9M |
| Total Assets | Q3 2024 · Jun 30, 2023 | $54.31M |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 48.45M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 47.46M sh |
| Operating Cash Flow | Q3 2024 · Mar 31, 2023 | −$3.29M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $42.55M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $43.63M |
| Stockholders Equity | Q3 2024 · Sep 30, 2022 | $44.84M |
| Stockholders Equity | Q3 2024 · Jun 30, 2022 | $46.4M |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$0.03 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$0.10 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | −$0.03 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | −$0.10 |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $242.86K |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $616.4K |
| Net Income | Q3 2024 · Mar 31, 2023 | −$1.65M |
| Net Income | Q3 2024 · Mar 31, 2023 | −$4.92M |
| Net Income | Q3 2024 · Dec 31, 2022 | −$1.43M |
| Net Income | Q3 2024 · Sep 30, 2022 | −$1.84M |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$1.57M |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$4.69M |